Skip to main content
Erschienen in:

01.03.2018 | Case report

Antivirals

Hepatic decompensation: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Auszug

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Liu C-H, et al. Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan. Journal of Gastroenterology and Hepatology 33: 710-717, No. 3, Mar 2018 - TaiwanCrossRefPubMed Liu C-H, et al. Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan. Journal of Gastroenterology and Hepatology 33: 710-717, No. 3, Mar 2018 - TaiwanCrossRefPubMed
Metadaten
Titel
Antivirals
Hepatic decompensation: case report
Publikationsdatum
01.03.2018
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2018
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-018-43453-7